Phathom Pharmaceuticals (PHAT) Other Non-Current Assets (2019 - 2026)

Phathom Pharmaceuticals (PHAT) has 8 years of Other Non-Current Assets data on file, last reported at $2.9 million in Q1 2026.

• On a quarterly basis, Other Non-Current Assets changed 0.03% year-over-year to $2.9 million in Q1 2026; TTM through Mar 2026 was $2.9 million, a 0.03% change from a year earlier, with the FY2025 full-year figure at $2.9 million, changed 0.03% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $2.9 million, roughly flat from $2.9 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for PHAT reached as high as $3.8 million in Q3 2023 and fell as low as $299000.0 in Q4 2022.
• Historically, Other Non-Current Assets has averaged $2.0 million across 5 years, with a median of $2.9 million in 2025.
• Across the five-year window, Other Non-Current Assets tumbled 62.86% in 2023 and jumped 858.86% in 2024, its largest moves.
• Year by year, Other Non-Current Assets stood at $299000.0 in 2022, then jumped by 465.89% to $1.7 million in 2023, then jumped by 69.15% to $2.9 million in 2024, then declined by 0.03% to $2.9 million in 2025, then changed by 0.0% to $2.9 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $2.9 million in Q1 2026, $2.9 million in Q4 2025, and $2.9 million in Q3 2025.